# Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

> **NCT07242664** · PHASE1 · RECRUITING · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 12 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitis

## Interventions

- **DRUG:** GZR-33

## Key facts

- **NCT ID:** NCT07242664
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-13
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-04-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242664, "Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07242664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*